Liberty Mutual Buys $681K More of Willow Tree Capital Corp

Illustration of an SEC Form 4 insider trading disclosure document with stock chart in background

A new Form 4 filing shows Liberty Mutual Holding Co Inc. adding to its stake in Willow Tree Capital Corp, a transaction that lands squarely in the open-market buy category insider trackers watch for. The filing, dated July 27, 2026, shows the purchase was made with the insider’s own capital rather than through options exercises … Read more

BXSY Insider Winmill Adds 5,000 More Shares in Buy Spree

Chart showing insider stock purchases at Bexil Investment Trust (BXSY) over one week

Winmill & Co. Inc, an insider at Bexil Investment Trust (BXSY), purchased 5,000 shares of the closed-end fund on July 29, 2026, paying $17.03 per share for a total outlay of $85,135.50. The shares were bought on the open market, meaning the insider used personal funds rather than receiving stock through options or grants. Following … Read more

BWMX Insider Luis Campos Buys 46,830 Shares for $768K

Stock chart and SEC Form 4 filing document representing an insider stock purchase at Betterware de Mexico (BWMX)

A fresh Form 4 filing shows Luis Campos, a Director and 10%+ Owner of Betterware de Mexico, S.A.P.I. de C.V. (NASDAQ: BWMX), went into the open market and bought more stock with his own money. The transaction, dated July 27, 2026, covered 46,830 shares at $16.41 apiece, for a total outlay of $768,480.30. This wasn’t … Read more

Scribe Therapeutics Director Gordon Buys $15M in SCTX Stock

SEC Form 4 filing details showing Carl L. Gordon's $15 million insider stock purchase in Scribe Therapeutics

Carl L. Gordon, a director at Scribe Therapeutics, Inc. (SCTX), disclosed an open-market purchase of 1,000,000 shares at $15.00 per share, a bet worth exactly $15,000,000.00, according to a Form 4 filed with the SEC. The transaction is dated July 27, 2026. Following the purchase, Gordon’s stake stands at 1,348,825 shares, held indirectly through a … Read more

SCTX Insider Buy: AH Bio Fund II Purchases $5M in Shares

SEC Form 4 filing document showing AH Bio Fund II's open-market purchase of Scribe Therapeutics shares

Another insider at Scribe Therapeutics, Inc. (SCTX) has stepped into the open market with a sizable purchase. According to a Form 4 filed with the SEC, AH Bio Fund II, L.P. bought 333,333 shares of the gene-editing biotech on July 27, 2026, paying $15.00 per share for a total outlay of $4,999,995.00. The transaction is … Read more

SCTX Insider Buy: OrbiMed Director Buys $15M in Shares

Chart showing OrbiMed Advisors' $15 million open-market purchase of Scribe Therapeutics (SCTX) shares

Insider trading today includes a notable open-market purchase at Scribe Therapeutics, Inc. (SCTX). A Form 4 filing shows OrbiMed Advisors LLC, listed as a director of the gene-editing company, bought 1,000,000 shares on July 27, 2026, at $15.00 per share for a total outlay of $15,000,000. The transaction was an open-market buy, meaning OrbiMed used … Read more

STFS: CFO Zhang Pingting Buys $2.6M in Open-Market Purchase

SEC Form 4 filing document showing an insider stock purchase by a company CFO

Star Fashion Culture Holdings Ltd (STFS) disclosed a notable insider purchase in a Form 4 filing this week, the kind of filing that regularly shows up when investors run an insider buying this week screener. Chief Financial Officer and Director Zhang Pingting bought 2,000,000 shares on the open market on July 22, 2026, at a … Read more

RA Capital Extends ARTV Buying Streak to $3M in Four Days

Chart showing RA Capital Management's cluster of insider stock purchases in Artiva Biotherapeutics between July 21 and July 24, 2026

RA Capital Management, L.P. added another purchase to its recent run of open-market buys in Artiva Biotherapeutics, Inc. (ARTV), according to a Form 4 filed with the SEC. On July 24, 2026, the investment firm bought 41,319 shares at $9.99 apiece, a purchase worth $412,776.81. Following the transaction, RA Capital’s indirectly held stake stands at … Read more

SCTX Insider Cluster Buy: Director Adds to $36M Buying Spree

Chart showing a cluster of insider stock purchases at Scribe Therapeutics between July 24 and July 28, 2026

Behzad Aghazadeh, a Director and 10%+ owner of Scribe Therapeutics, Inc. (SCTX), purchased 7,905 shares of the gene-editing company on July 28, 2026, paying $18.25 per share for a total outlay of $144,266.25. The shares were acquired on the open market, meaning Aghazadeh used personal funds rather than receiving the stock through options or other … Read more

Liberty Mutual Holding Buys $8.2M in 5C Lending Partners Shares

Chart showing insider stock purchase pattern for 5C Lending Partners Corp with two open-market buys in July 2026

A fresh Form 4 filing shows Liberty Mutual Holding Co Inc. adding to its stake in 5C Lending Partners Corp. through an open-market purchase dated July 24, 2026. The insider bought 337,966 shares at $24.29 apiece, a transaction worth $8,209,194.14. Following the purchase, Liberty Mutual Holding’s position stands at 2,269,965 shares, held indirectly through a … Read more

MSD Capital Buys $31M of 5C Lending Partners Shares

SEC Form 4 filing document showing an insider stock purchase transaction

A fresh Form 4 filing shows MSD Capital, L.P. has made a sizable open-market purchase of 5C Lending Partners Corp. stock, the kind of large insider buy that tends to catch the attention of anyone running an insider trading screener for the day’s biggest moves. According to the disclosure, MSD Capital bought 1,274,194 shares on … Read more

MTAK Insider Buys $4.5M in Shares at $10 Apiece

SEC Form 4 filing details showing Market Technology Acquisition Sponsor LLC's purchase of MTAK shares

Market Technology Acquisition Sponsor LLC, listed as a 10%+ owner of Market Technology Acquisition Corp (MTAK), disclosed an open-market purchase of 452,500 shares on July 27, 2026, according to a Form 4 filed with the SEC. The shares were bought at $10.00 each, for a total outlay of $4,525,000.00, funded directly by the sponsor entity … Read more